Clinical Trials Logo

Parkinson's Disease clinical trials

View clinical trials related to Parkinson's Disease.

Filter by:

NCT ID: NCT02927691 Completed - Parkinson's Disease Clinical Trials

Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial

Start date: September 2016
Phase: Phase 2
Study type: Interventional

Currently, there are no efficacious behavioral treatment approaches to address uncompensated aspiration, or aspiration without appropriate cough response, in Parkinson's disease (PD). This is of particular public health concern given that aspiration pneumonia is the leading cause of death in persons with PD. The overarching aim of the proposed study is to determine the efficacy of two distinct intensive rehabilitation paradigms, expiratory muscle strength training (EMST) and sensorimotor treatment for airway protection (smTAP), on airway protective clinical outcomes in persons with PD and dysphagia. The investigators anticipate the results will lead to reductions in the risks associated with airway protective deficits.

NCT ID: NCT02925065 Completed - Parkinson's Disease Clinical Trials

Impact of Non-traditional Guitar Group Instruction on Functional Movement and Well-being in Parkinson's Disease Patients

PD/Guitar
Start date: March 5, 2018
Phase: N/A
Study type: Interventional

This controlled prospective cohort study is designed to assess the feasibility and effect of twice-weekly 60 minute non-traditional guitar classes on PD patient's self-reported and measurable outcomes including upper extremity function, motor findings, quality of life, mood, and cognitive findings. 24-30 individuals with PD will be randomly assigned to an early-start and a late-start guitar instruction group. Prior to conducting a larger study, this study seeks to assess the possibility that participation in an instrumental performance activity in a group setting may improve outcomes in PD patients.

NCT ID: NCT02915848 Completed - Parkinson's Disease Clinical Trials

Long-term Stability of LFP Recorded From the STN and the Effects of DBS

Start date: September 9, 2016
Phase:
Study type: Observational

Movement disorders such as Parkinson Disease, dystonia, and tremor are related to abnormalities of part of the brain known as the basal ganglia. Recently, it has been suggested that the basal ganglia works by oscillations (group of neurons cycle between activation/deactivation when stimulated) of electrical signals. A treatment that involves insertion of electrodes in the subthalamic nucleus (STN) for electrical stimulation, known as deep brain stimulation (DBS), is an established treatment for advanced Parkinson's disease. However its mechanism of action is still not completely understood. Currently, DBS utilizes an "open loop" system whereby the stimulation settings are manually adjusted depending on the patients' clinical response. 1. Determine whether the local field potential (LFP) recorded from the STN is stable over a 1.5 year period. 2. Address whether STN LFP is a suitable control signal, and how it should be used to change DBS parameters

NCT ID: NCT02912871 Completed - Parkinson's Disease Clinical Trials

Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease

Start date: April 2016
Phase: N/A
Study type: Interventional

Based on published animal and human studies, ExAblate Transcranial subthalamotomy can be as safe and as effective as any of the surgical treatments within the currently accepted standard of care including radiofrequency lesioning and Deep Brain Stimulation (DBS). A unilateral lesion of the subthalamic nucleus has shown reduction of contralateral motor symptoms in Parkinson's disease (PD). Using ExAblate Transcranial Magnetic Resonance guided High Intensity Focused Ultrasound (MRgHIFU) to create the subthalamotomy has several potential advantages over current therapies including the fact that transcranial lesioning can be performed in a precise manner with simultaneous as well as continuous clinical and radiographic monitoring. If the potential of ExAblate Transcranial subthalamotomy can be realized, it could supplant radiofrequency and radiosurgery techniques and provide a viable alternative procedure for subjects considering DBS.

NCT ID: NCT02902510 Completed - Parkinson's Disease Clinical Trials

Therapeutic Yoga to Improve Function in Parkinson's Disease

Start date: April 2015
Phase: N/A
Study type: Interventional

This is a single blind, randomized, wait-list controlled, phase II exploratory pilot study.

NCT ID: NCT02898740 Completed - Parkinson's Disease Clinical Trials

Telephone-linked Home-based Exercise Training in PD

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

This project is investigating whether a home-based exercise program will reduce depression in patients with Parkinson's disease.

NCT ID: NCT02895932 Completed - Parkinson's Disease Clinical Trials

Serotonin and Amyloidopathy

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if changes in brain serotonin affects the accumulation of amyloid in the brain. The investigators will use brain imaging methods to measure the amount of serotonin and amyloid in the brain of individuals with Parkinson's Disease (PD) and otherwise healthy older people. PD participants will undergo repeat brain imaging to assess amyloid accumulation two years after their first brain imaging session. All participants will undergo examinations to assess their motor function, and asked questions to assess their mood and thinking.

NCT ID: NCT02894320 Completed - Parkinson's Disease Clinical Trials

Dynamic ASPECTS of Internal PRE-ACTIVATION of Effects Sensors of Voluntary ACTION in PARKINSON's Disease

DYNIDEO
Start date: March 2015
Phase:
Study type: Observational

The ability to predict sensory effects of people's own motor actions is a key component of Human action realization. Recent studies revealed this anticipation process to be involved in early and late stages of voluntary actions. Nevertheless, the question whether the action-effect anticipation is impacted or not by "motor pathologies", such as the Parkinson's disease, remains unclear. The current study is aimed to clarify this issue by using a subliminal priming paradigm in patients with Parkinson's disease and in matched control participants. Indeed, subliminal primes corresponding to visual action-effects are displayed at different time points before the actions' execution. Results should allow to determine whether or not the action-effect prediction is impaired at different stages of voluntary action in patients with Parkinson's disease.

NCT ID: NCT02893449 Completed - Parkinson's Disease Clinical Trials

Psychiatry Study: Parkinson Disease

Start date: April 2009
Phase: N/A
Study type: Interventional

Main objective: To assess the impact of a structured program of preoperative cognitive remediation on postoperative social adaptation in patients suffering from Parkinson's disease profiting from bilateral subthalamic nucleus stimulation. Secondary objectives: To assess in the same patients the impact of structured program of preoperative cognitive remediation on quality of life, mood, anxiety, apathy and psychologic, social and professional functioning depending on psychiatric symptomatology after intervention.

NCT ID: NCT02891473 Completed - Parkinson's Disease Clinical Trials

A Rehabilitative Approach in Patients With Parkinson's Disease

Start date: July 2015
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the effectiveness of a rehabilitative approach using breathing and relaxation techniques, and specifically the elongation of the latissimus dorsi muscle according to the Mézières Method to improve balance and posture and relief pain in patients with Parkinson's disease.